BNT162b2 (Pfizer/BioNTech) COVID-19 Vaccination Was Not Associated with the Progression of Activity of the Exudative Form of Age-Related Macular Degeneration during Anti-VEGF Therapy

Background: Evaluation of the activity of the exudative form of age-related macular degeneration (AMD) during anti-vascular endothelial growth factor (anti-VEGF) therapy before and after administration of BNT162b2 (Pfizer/BioNTech) vaccination. Methods: The optical coherence tomography and best corr...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Bernadetta Płatkowska-Adamska, Agnieszka Bociek, Joanna Krupińska, Magdalena Kal, Michał Biskup, Dorota Zarębska-Michaluk, Dominik Odrobina
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2022-11-01
Edice:	Vaccines
Témata:	age-related macular degeneration COVID-19 vaccine BNT162b2
On-line přístup:	https://www.mdpi.com/2076-393X/10/11/1878
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!